Mylan Agrees to Pay $465 Million for Ripping Off Medicare on EpiPens, Stock Price Soars
Mylan CEO Heather Bresch listens to an aide during a hearing before lying to the House Oversight and Government Reform Committee on September 21, 2016 (Photo by Alex Wong/Getty Images) Mylan, the drug company that makes EpiPen, has been overcharging Medicare and Medicaid for years. But today the pharmaceutical company had to finally pay the…